Common Shares Outstanding: The number of class A shares currently held by investors.
DMK Pharmaceuticals Corporation (DMKPQ) had Common Shares Outstanding of 10.09M for the most recently reported fiscal quarter, ending 2023-09-30.
Income Statement Financials | |
$0.01M |
|
$-1.39M |
|
$0.34M |
|
$-0.33M |
|
$3.27M |
|
$-3.27M |
|
$1.53M |
|
$-1.74M |
|
$-1.74M |
|
$-1.74M |
|
$-1.74M |
|
$-1.39M |
|
$-1.74M |
|
$-3.27M |
|
$-3.20M |
|
7.07M |
|
7.07M |
|
$-0.20 |
|
$-0.20 |
|
Balance Sheet Financials | |
$7.87M |
|
$1.08M |
|
$1.09M |
|
$8.96M |
|
$13.46M |
|
-- |
|
$0.79M |
|
$14.25M |
|
$-5.29M |
|
$-5.29M |
|
$-5.29M |
|
Common Shares Outstanding |
10.09M |
Cash Flow Statement Financials | |
$-7.85M |
|
$2.75M |
|
$10.69M |
|
$1.11M |
|
$6.66M |
|
$5.55M |
|
$0.08M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3635.25% |
|
-36030.73% |
|
-36030.73% |
|
-- |
|
-19159.66% |
|
-15317.21% |
|
$-7.85M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.51 |
|
-- |
|
-- |
|
32.79% |
|
32.79% |
|
-19.38% |
|
32.79% |
|
$-0.52 |
|
$-1.11 |
|
$-1.11 |